JAK“新秀”乌帕替尼治疗活动性强直性脊柱炎如何？国内怎么购买？

A JAK1 inhibitor that has shown good efficacy in clinical trials for the treatment of a variety of autoimmune and inflammatory diseases was launched in the United States in 2019 and can be used as a monotherapy or in combination with methotrexate or other non-biological antirheumatic drugs (DMARDs). Today let’s take a closer look at how to buy Upatinib in China?

Upatinib is currently an unmarketed drug in China, which means that patients with ankylosing spondylitis cannot purchase this drug domestically and need to go abroad to purchase it. However, this imposes a heavy financial burden and is not suitable for patients to take the drug for a long time. However, it is inconvenient for many patients to go abroad. At this time, it is recommended to obtain Upatinib through medical companion travel. Direct mail from overseas pharmaceutical companies is affordable and cost-effective, and it can guarantee that the drug is genuine. Obtaining medicines through medical companion travel eliminates the trouble of going abroad to purchase medicines and also reduces the financial burden on patients. For the specific price and purchase process of upadatinib, patients can consult the medical companion and travel service staff. The editor does not recommend that patients obtain drugs through purchasing agents, as it is easy to be deceived.

Upatinib was launched in the United States and was approved to treat patients with moderate to severe rheumatoid arthritis in 2019. Shortly after, the drug submitted a new indication application for ankylosing spondylitis. According to the results of the key clinical trial SELECT-AXIS 1, the efficacy of upadatinib in treating AS for 64 weeks was maintained and continuously improved, significantly reducing disease activity and improving patient response. It is 15mg, once a day, and the safety is controllable. Common adverse reactions are mainly upper respiratory tract infection, nausea, cough and fever. Patients should pay attention to their own reactions during medication. If they are intolerant, contact their doctor promptly and adopt a new treatment plan.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: